nodes	percent_of_prediction	percent_of_DWPC	metapath
Pilocarpine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00801	0.0868	CbGeAlD
Pilocarpine—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00729	0.079	CbGeAlD
Pilocarpine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00677	0.0734	CbGeAlD
Pilocarpine—CHRM3—forebrain—attention deficit hyperactivity disorder	0.00652	0.0707	CbGeAlD
Pilocarpine—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00616	0.0668	CbGeAlD
Pilocarpine—CYP2A6—cerebellum—attention deficit hyperactivity disorder	0.00481	0.0522	CbGeAlD
Pilocarpine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00435	0.0471	CbGeAlD
Pilocarpine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00418	0.0454	CbGeAlD
Pilocarpine—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00396	0.0429	CbGeAlD
Pilocarpine—CYP2A6—brain—attention deficit hyperactivity disorder	0.00391	0.0424	CbGeAlD
Pilocarpine—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00381	0.0413	CbGeAlD
Pilocarpine—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.00377	0.0408	CbGeAlD
Pilocarpine—CHRM3—nervous system—attention deficit hyperactivity disorder	0.00354	0.0384	CbGeAlD
Pilocarpine—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00341	0.037	CbGeAlD
Pilocarpine—CHRM2—brain—attention deficit hyperactivity disorder	0.00332	0.036	CbGeAlD
Pilocarpine—CHRM1—brain—attention deficit hyperactivity disorder	0.00302	0.0328	CbGeAlD
Pilocarpine—CHRM3—brain—attention deficit hyperactivity disorder	0.00271	0.0293	CbGeAlD
Pilocarpine—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.00242	0.0262	CbGeAlD
Pilocarpine—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.00233	0.0252	CbGeAlD
Pilocarpine—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.00227	0.0247	CbGeAlD
Pilocarpine—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00205	0.00225	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00199	0.00219	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00199	0.00219	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00198	0.00219	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00197	0.00216	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00195	0.00215	CbGpPWpGaD
Pilocarpine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00195	0.0211	CbGeAlD
Pilocarpine—CHRM3—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00194	0.00214	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00193	0.00213	CbGpPWpGaD
Pilocarpine—CHRM2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00193	0.00212	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00193	0.00212	CbGpPWpGaD
Pilocarpine—CYP2A6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00188	0.00207	CbGpPWpGaD
Pilocarpine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00187	0.0203	CbGeAlD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00187	0.00206	CbGpPWpGaD
Pilocarpine—CYP2A6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00186	0.00205	CbGpPWpGaD
Pilocarpine—CYP2E1—brain—attention deficit hyperactivity disorder	0.00185	0.02	CbGeAlD
Pilocarpine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00181	0.002	CbGpPWpGaD
Pilocarpine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00181	0.00199	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.0018	0.00199	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.0018	0.00198	CbGpPWpGaD
Pilocarpine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00179	0.00197	CbGpPWpGaD
Pilocarpine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00178	0.00196	CbGpPWpGaD
Pilocarpine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00177	0.00195	CbGpPWpGaD
Pilocarpine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00175	0.00193	CbGpPWpGaD
Pilocarpine—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00173	0.00191	CbGpPWpGaD
Pilocarpine—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.0017	0.00188	CbGpPWpGaD
Pilocarpine—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00168	0.00185	CbGpPWpGaD
Pilocarpine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00168	0.00185	CbGpPWpGaD
Pilocarpine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00168	0.00185	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00168	0.00185	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00167	0.00184	CbGpPWpGaD
Pilocarpine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00166	0.00183	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00166	0.00182	CbGpPWpGaD
Pilocarpine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00163	0.0018	CbGpPWpGaD
Pilocarpine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00163	0.00179	CbGpPWpGaD
Pilocarpine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00161	0.00177	CbGpPWpGaD
Pilocarpine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.0016	0.00177	CbGpPWpGaD
Pilocarpine—CHRM3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.0016	0.00176	CbGpPWpGaD
Pilocarpine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00158	0.00174	CbGpPWpGaD
Pilocarpine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00158	0.00174	CbGpPWpGaD
Pilocarpine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00158	0.00174	CbGpPWpGaD
Pilocarpine—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00157	0.00173	CbGpPWpGaD
Pilocarpine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00156	0.00172	CbGpPWpGaD
Pilocarpine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00155	0.00171	CbGpPWpGaD
Pilocarpine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00155	0.0017	CbGpPWpGaD
Pilocarpine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00153	0.00169	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00152	0.00168	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00152	0.00168	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00152	0.00167	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.0015	0.00166	CbGpPWpGaD
Pilocarpine—CYP2E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00148	0.00163	CbGpPWpGaD
Pilocarpine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00147	0.00162	CbGpPWpGaD
Pilocarpine—CYP2E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00147	0.00162	CbGpPWpGaD
Pilocarpine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00147	0.00162	CbGpPWpGaD
Pilocarpine—CYP2E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00146	0.00161	CbGpPWpGaD
Pilocarpine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00146	0.0016	CbGpPWpGaD
Pilocarpine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00144	0.00159	CbGpPWpGaD
Pilocarpine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00144	0.00158	CbGpPWpGaD
Pilocarpine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00142	0.00157	CbGpPWpGaD
Pilocarpine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.0014	0.00154	CbGpPWpGaD
Pilocarpine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00139	0.00153	CbGpPWpGaD
Pilocarpine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00138	0.00152	CbGpPWpGaD
Pilocarpine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00137	0.00151	CbGpPWpGaD
Pilocarpine—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00137	0.00151	CbGpPWpGaD
Pilocarpine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00136	0.00149	CbGpPWpGaD
Pilocarpine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00136	0.00149	CbGpPWpGaD
Pilocarpine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00135	0.00149	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00135	0.00149	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00135	0.00148	CbGpPWpGaD
Pilocarpine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00134	0.00147	CbGpPWpGaD
Pilocarpine—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00134	0.00147	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00133	0.00147	CbGpPWpGaD
Pilocarpine—CHRM3—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00133	0.00147	CbGpPWpGaD
Pilocarpine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00129	0.00142	CbGpPWpGaD
Pilocarpine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00126	0.00139	CbGpPWpGaD
Pilocarpine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00126	0.00139	CbGpPWpGaD
Pilocarpine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00125	0.00137	CbGpPWpGaD
Pilocarpine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.0012	0.00132	CbGpPWpGaD
Pilocarpine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00119	0.00131	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00118	0.0013	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00118	0.0013	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00117	0.00128	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00112	0.00124	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00112	0.00124	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00111	0.00122	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.0011	0.00121	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.0011	0.00121	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0011	0.00121	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00109	0.00121	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00109	0.0012	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00108	0.00119	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00106	0.00117	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00106	0.00117	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00105	0.00116	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00105	0.00115	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00104	0.00115	CbGpPWpGaD
Pilocarpine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00103	0.00114	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00103	0.00114	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00103	0.00114	CbGpPWpGaD
Pilocarpine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00103	0.00113	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00103	0.00113	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00102	0.00113	CbGpPWpGaD
Pilocarpine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00102	0.00112	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00102	0.00112	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00102	0.00112	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00101	0.00111	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.001	0.0011	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000998	0.0011	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000988	0.00109	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000962	0.00106	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000959	0.00106	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00095	0.00105	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.0009	0.000991	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000897	0.000988	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000888	0.000978	CbGpPWpGaD
Pilocarpine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000885	0.000975	CbGpPWpGaD
Pilocarpine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000882	0.000972	CbGpPWpGaD
Pilocarpine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000874	0.000962	CbGpPWpGaD
Pilocarpine—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000808	0.00089	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000767	0.000845	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000764	0.000842	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000762	0.000839	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000754	0.000831	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000719	0.000793	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000702	0.000774	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.0007	0.000771	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000694	0.000764	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000693	0.000764	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000692	0.000762	CbGpPWpGaD
Pilocarpine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000688	0.000758	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000685	0.000754	CbGpPWpGaD
Pilocarpine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000683	0.000752	CbGpPWpGaD
Pilocarpine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000678	0.000747	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000674	0.000742	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000672	0.00074	CbGpPWpGaD
Pilocarpine—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000668	0.000736	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000668	0.000736	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000666	0.000733	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000665	0.000733	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000659	0.000726	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000621	0.000684	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000619	0.000682	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000613	0.000675	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000606	0.000668	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000606	0.000668	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000604	0.000666	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000603	0.000665	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000602	0.000663	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000601	0.000662	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000599	0.00066	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000599	0.000659	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000596	0.000656	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000593	0.000654	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000591	0.000651	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000591	0.000651	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000589	0.000649	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000589	0.000649	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000584	0.000643	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000584	0.000643	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000583	0.000643	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000582	0.000641	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00058	0.000639	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000578	0.000637	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000576	0.000635	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000572	0.00063	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000564	0.000621	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000562	0.000619	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000556	0.000613	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000546	0.000601	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000544	0.0006	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000544	0.000599	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000542	0.000597	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000539	0.000594	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000537	0.000591	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000537	0.000591	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000535	0.000589	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00053	0.000584	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00053	0.000584	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000529	0.000583	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000529	0.000583	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000528	0.000582	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000523	0.000576	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000521	0.000574	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000497	0.000547	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000497	0.000547	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000494	0.000544	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000492	0.000542	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000489	0.000538	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000487	0.000537	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000484	0.000533	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000454	0.0005	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000423	0.000466	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000418	0.000461	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000418	0.000461	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000412	0.000453	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00041	0.000451	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000409	0.00045	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000405	0.000446	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000403	0.000444	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000397	0.000437	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000383	0.000422	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000381	0.000419	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00038	0.000418	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000378	0.000416	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000376	0.000414	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000358	0.000395	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000357	0.000393	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000354	0.00039	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000346	0.000381	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000345	0.00038	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000341	0.000376	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000335	0.000368	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000333	0.000367	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000332	0.000366	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000329	0.000362	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000323	0.000355	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000321	0.000354	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000321	0.000353	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000319	0.000351	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000318	0.000351	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000318	0.000351	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000317	0.000349	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000316	0.000348	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000313	0.000345	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000313	0.000345	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000312	0.000344	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000309	0.00034	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000301	0.000331	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000299	0.000329	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000292	0.000321	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000291	0.00032	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000288	0.000317	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000281	0.00031	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000254	0.000279	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000252	0.000277	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000204	0.000225	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000204	0.000224	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000202	0.000222	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000194	0.000214	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000194	0.000214	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000191	0.00021	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000178	0.000196	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000155	0.000171	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000148	0.000163	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—EP300—attention deficit hyperactivity disorder	0.000138	0.000152	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	0.000129	0.000142	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000118	0.00013	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000117	0.000129	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000109	0.00012	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000108	0.000119	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000108	0.000119	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000107	0.000118	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	5.04e-05	5.56e-05	CbGpPWpGaD
